2 reports

In the study, ## patients were randomized ##:##:## to receive placebo, baricitinib ## mg or baricitinib ## mg.

  • Cell Therapy
  • Genitourinary System Disease
  • Musculoskeletal Disorder
  • World
  • GlaxoSmithKline plc

It is also under development for prevention of smallpox, Ebola and Marburg infections and Equine encephalitis infections (as a countermeasure against bioterrorism).

  • Genitourinary System Disease
  • Type 2 Diabetes
  • United States
  • Company Operations
  • Product Initiative